Literature DB >> 31170010

Adenoviral gene transfer of a single-chain IL-23 induces psoriatic arthritis-like symptoms in NOD mice.

Rafael R Flores1,2,3,4, Lana Carbo3,4, Eun Kim5, Montina Van Meter3,4, Consuelo M Lopez De Padilla6, Jing Zhao3,4, Debora Colangelo1,2,7, Matthew J Yousefzadeh1,2,3,4, Luise A Angelini1,2,3,4, Lei Zhang1,2, Enrico Pola7, Nam Vo8, Christopher H Evans6, Andrea Gambotto5,9, Laura J Niedernhofer1,2,3,4, Paul D Robbins1,2,3,4.   

Abstract

Previously, we demonstrated that intratumoral delivery of adenoviral vector encoding single-chain (sc)IL-23 (Ad.scIL-23) was able to induce systemic antitumor immunity. Here, we examined the role of IL-23 in diabetes in nonobese diabetic mice. Intravenous delivery of Ad.scIL-23 did not accelerate the onset of hyperglycemia but instead resulted in the development of psoriatic arthritis. Ad.scIL-23-treated mice developed erythema, scales, and thickening of the skin, as well as intervertebral disc degeneration and extensive synovial hypertrophy and loss of articular cartilage in the knees. Immunological analysis revealed activation of conventional T helper type 17 cells and IL-17-producing γδ T cells along with a significant depletion and suppression of T cells in the pancreatic lymph nodes. Furthermore, treatment with anti-IL-17 antibody reduced joint and skin psoriatic arthritis pathologies. Thus, these Ad.scIL-23-treated mice represent a physiologically relevant model of psoriatic arthritis for understanding disease progression and for testing therapeutic approaches.-Flores, R. R., Carbo, L., Kim, E., Van Meter, M., De Padilla, C. M. L., Zhao, J., Colangelo, D., Yousefzadeh, M. J., Angelini, L. A., Zhang, L., Pola, E., Vo, N., Evans, C. H., Gambotto, A., Niedernhofer, L. J., Robbins, P. D. Adenoviral gene transfer of a single-chain IL-23 induces psoriatic arthritis-like symptoms in NOD mice.

Entities:  

Keywords:  adenovirus; interleukin-17; interleukin-23; psoriasis; type 1 diabetes

Mesh:

Substances:

Year:  2019        PMID: 31170010      PMCID: PMC6662986          DOI: 10.1096/fj.201900420R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.834


  67 in total

Review 1.  Psoriasis.

Authors:  Michael P Schön; W-Henning Boehncke
Journal:  N Engl J Med       Date:  2005-05-05       Impact factor: 91.245

2.  STAT3 and NF-kappaB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice.

Authors:  Mi-La Cho; Jung-Won Kang; Young-Mee Moon; Hyo-Jung Nam; Joo-Yeon Jhun; Seong-Beom Heo; Hyun-Tak Jin; So-Youn Min; Ji-Hyeon Ju; Kyung-Su Park; Young-Gyu Cho; Chong-Hyeon Yoon; Sung-Hwan Park; Young-Chul Sung; Ho-Youn Kim
Journal:  J Immunol       Date:  2006-05-01       Impact factor: 5.422

3.  Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis.

Authors:  B J Nickoloff; T Wrone-Smith
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

4.  Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-alpha and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice.

Authors:  D G Alleva; R P Pavlovich; C Grant; S B Kaser; D I Beller
Journal:  Diabetes       Date:  2000-07       Impact factor: 9.461

5.  Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation.

Authors:  Athanasios Stratis; Manolis Pasparakis; Rudolf A Rupec; Doreen Markur; Karin Hartmann; Karin Scharffetter-Kochanek; Thorsten Peters; Nico van Rooijen; Thomas Krieg; Ingo Haase
Journal:  J Clin Invest       Date:  2006-08       Impact factor: 14.808

6.  The antitumor effects of adenoviral-mediated, intratumoral delivery of interleukin 23 require endogenous IL-12.

Authors:  J Reay; A Gambotto; P D Robbins
Journal:  Cancer Gene Ther       Date:  2011-12-09       Impact factor: 5.987

7.  Inflammatory skin disease in K14/p40 transgenic mice: evidence for interleukin-12-like activities of p40.

Authors:  T Kopp; J D Kieffer; A Rot; S Strommer; G Stingl; T S Kupper
Journal:  J Invest Dermatol       Date:  2001-09       Impact factor: 8.551

Review 8.  Management of psoriatic arthritis: Early diagnosis, monitoring of disease severity and cutting edge therapies.

Authors:  Siba P Raychaudhuri; Reason Wilken; Andrea C Sukhov; Smriti K Raychaudhuri; Emanual Maverakis
Journal:  J Autoimmun       Date:  2016-11-09       Impact factor: 7.094

9.  Inflammatory skin disease in transgenic mice that express high levels of interleukin 1 alpha in basal epidermis.

Authors:  R W Groves; H Mizutani; J D Kieffer; T S Kupper
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

10.  The flaky skin (fsn) mutation in mice: map location and description of the anemia.

Authors:  W G Beamer; S C Pelsue; L D Shultz; J P Sundberg; J E Barker
Journal:  Blood       Date:  1995-10-15       Impact factor: 22.113

View more
  5 in total

1.  The Protective Role of pVHL in Imiquimod-Induced Psoriasis-like Skin Inflammation.

Authors:  Isaí Martínez-Torres; Araceli Tepale-Segura; Octavio Castro-Escamilla; Juan Carlos Cancino-Diaz; Sandra Rodríguez-Martínez; Sonia Mayra Perez-Tapia; Laura C Bonifaz; Mario Eugenio Cancino-Diaz
Journal:  Int J Mol Sci       Date:  2022-05-07       Impact factor: 6.208

Review 2.  Advances in Juvenile Spondyloarthritis.

Authors:  Hemalatha Srinivasalu; Erin Brennan Treemarcki; Christopher Redmond
Journal:  Curr Rheumatol Rep       Date:  2021-07-13       Impact factor: 4.592

Review 3.  Molecular Insights Into Lysyl Oxidases in Cartilage Regeneration and Rejuvenation.

Authors:  Weiping Lin; Liangliang Xu; Gang Li
Journal:  Front Bioeng Biotechnol       Date:  2020-04-30

4.  Layered dissolving microneedles as a need-based delivery system to simultaneously alleviate skin and joint lesions in psoriatic arthritis.

Authors:  Kaiyue Yu; Xiuming Yu; Sisi Cao; Yixuan Wang; Yuanhao Zhai; Fengdie Yang; Xiaoyuan Yang; Yi Lu; Chuanbin Wu; Yuehong Xu
Journal:  Acta Pharm Sin B       Date:  2020-08-28       Impact factor: 11.413

5.  IL-23 orchestrating immune cell activation in arthritis.

Authors:  Aurélie Najm; Iain B McInnes
Journal:  Rheumatology (Oxford)       Date:  2021-10-19       Impact factor: 7.580

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.